Estrogens and progestins and internal contraceptives

The market for estrogens and progestins and internal contraceptives is worth about R1.9 million, which is a relatively small but specific niche. Unfortunately, it's not growing, with zero year-on-year growth, so you'll need to be strategic to get a foothold. It's also a very crowded market, with only one supplier currently serving one department, so you'll need to differentiate your organisation to stand out. The good news is that there's a strong favour towards black-owned, women-owned, and youth-owned businesses, with allocations of around 44.75%, 13.23%, and 14.86% respectively. If I were you, I'd focus on building a strong B-BBEE level, particularly if you're a black-owned, women-owned, or youth-owned business, to increase your chances of securing a contract in this programme.

ProTenders Intelligence, powered by National Treasury BAS data